Long-term outcomes after liver transplantation in children

Current Opinion in Organ Transplantation

Volumn 13, Issue 3, 2008, Pages 247-251

  Bucuvalas, John C ^a   Alonso, Estella ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Adherence; Health related quality of life; Late allograft dysfunction; Pediatric liver transplantation

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID; NITISINONE; RAPAMYCIN; TACROLIMUS;

ALLOGRAFT; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; GLOMERULAR DYSFUNCTION; GRAFT FAILURE; GRAFT REJECTION; GROUPS BY AGE; GROWTH; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KNOWLEDGE; LIVER TRANSPLANTATION; LOW DRUG DOSE; NEPHROTOXICITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEDIATRICS; PREDICTOR VARIABLE; QUALITY OF LIFE; RECIPIENT; REVIEW; RISK FACTOR; SURVIVOR; TUBULAR DYSFUNCTION; AGE; CHILD; KIDNEY DISEASE; TREATMENT OUTCOME;

AGE FACTORS; CHILD; GRAFT REJECTION; GROWTH; HUMANS; KIDNEY DISEASES; LIVER TRANSPLANTATION; PATIENT COMPLIANCE; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 54549086596     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e3282f94aab     Document Type: Review

References (38)

1. Mazariegos GV, Reyes J, Marino IR, et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997; 63:243-249.
2. Oike F, Yokoi A, Nishimura E, et al. Complete withdrawal of immunosuppression in living donor liver transplantation. Transplant Proc 2002; 34:1521.
3. Ramos HC, Reyes J, Abu-Elmagd K, et al. Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995; 59:212-217.
4. Berquist RK, Berquist WE, Esquivel CO, et al. Adolescent nonadherence: prevalence and consequences in liver transplant recipients. Pediatr Transplant 2006; 10:304-310.
5. Reding R. Long-term complications of immunosuppression in pediatric liver recipients. Acta Gastroenterol Belg 2005; 68:453-456.
6. Shemesh E. Nonadherence to medications following pediatric liver transplantation. Pediatr Transplant 2004; 8:600-605.
7. Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004; 113:825-832.
8. Butler JA, Roderick P, Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 2004; 77:769-776.
9. Fredericks EM, Lopez MJ, Magee JC, et al. Psychological functioning, nonadherence and health outcomes after pediatric liver transplantation. Am J Transplant 2007; 7:1974-1983.
10. Kerkar N, Annunziato RA, Foley L, et al. Prospective analysis of nonadherence in autoimmune hepatitis: a common problem. J Pediatr Gastroenterol Nutr 2006; 43:629-634.
11. Venkat NT, Wang Y, Bucuvalas J. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to nonadherence. J Pediatr Gastroenterol Nutr 2008; 12:67-72.
12. Emre S. Posttraumatic stress disorder in posttransplant children: creating a clinical programto address their needs. CNSSpectr 2006; 11:118, 120-126.
13. Lurie S, Shemesh E, Sheiner PA, et al. Nonadherence in pediatric liver transplant recipients: an assessment of risk factors and natural history. Pediatr Transplant 2000; 4:200-206.
14. Shemesh E, Annunziato RA, Yehuda R, et al. Childhood abuse, nonadherence, and medical outcome in pediatric liver transplant recipients. J Am Acad Child Adolesc Psychiatry 2007; 46:1280-1289.
15. Sundaram SS, Landgraf JM, Neighbors K, et al. Adolescent health-related quality of life following liver and kidney transplantation. Am J Transplant 2007; 7:982-989.
16. Barshes NR, Chang IF, Karpen SJ, et al. Impact of pretransplant growth retardation in pediatric liver transplantation. J Pediatr Gastroenterol Nutr 2006; 43:89-94.
17. Khan K, Raatz S, Sharp H. Bone mineral density in adults transplanted in childhood for liver disease. Transplant Proc 2006; 38:1453-1455.
18. McDiarmid SV, Gornbein JA, DeSilva PJ, et al. Factors affecting growth after pediatric liver transplantation. Transplantation 1999; 67:404-411.
19. Gonwa TA, Mai ML, Melton LB, et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment. Transplantation 2001; 72:1934-1939.
20. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349:931-940.
21. Campbell KM, Yazigi N, Ryckman FC, et al. High prevalence of renal dysfunction in long-termsurvivors after pediatric liver transplantation. J Pediatr 2006; 148:475-480.
22. Alonso EM. Long-term renal function in pediatric liver and heart recipients. Pediatr Transplant 2004; 8:381-385.
23. Aw MM, Samaroo B, Baker AJ, et al. Calcineurin-inhibitor related nephrotoxicity: reversibility in paediatric liver transplant recipients. Transplantation 2001; 72:746-749.
24. Fine RN. Renal function following liver transplantation in children. Pediatr Transplant 2005; 9:680-684.
25. Kalicinski P, Szymczak M, Smirska E, et al. Longitudinal study of renal function in pediatric liver transplant recipients. Ann Transplant 2005; 10:53-58.
26. McDiarmid SV. Renal function in pediatric liver transplant recipients. Transplantation 2001; 72:561-562.
27. Campbell MS, Kotlyar DS, Brensinger CM, et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005; 11:1048-1055.
28. Velidedeoglu E, Bloom RD, Crawford MD, et al. Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation 2004; 77:553-556.
29. Velidedeoglu E, Crawford MD, Desai NM, et al. Predictors of late kidney dysfunction postliver transplantation. Transplant Proc 2002; 34:3315-3316.
30. Berg UB, Ericzon BG, Nemeth A. Renal function before and long after liver transplantation in children. Transplantation 2001; 72:631-637.
31. Herzog D, Martin S, Turpin S, Alvarez F. Normal glomerular filtration rate in long-term follow-up of children after orthotopic liver transplantation. Transplantation 2006; 81:672-677.
32. Pierik LJ, van Spronsen FJ, Bijleveld CM, van Dael CM. Renal function in tyrosinaemia type I after liver transplantation: a long-term follow-up. J Inherit Metab Dis 2005; 28:871-876.
33. Tannuri U, Gibelli NE, Maksoud-Filho JG, et al. Mycophenolate mofetil promotes prolonged improvement of renal dysfunction after pediatric liver transplantation: experience of a single center. Pediatr Transplant 2007; 11:82-86.
34. Pageaux GP, Rostaing L, Calmus Y, et al. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Liver Transpl 2006; 12:1755-1760.
35. Markiewicz M, Kalicinski P, Teisseyre J, et al. Rapamycin in children after liver transplantation. Transplant Proc 2003; 35:2284-2286.
36. Soltys KA, Mazariegos GV, Squires RH, et al. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant 2007; 7:2165-2171.
37. Mieli-Vergani G, Vergani D. De novo autoimmune hepatitis after liver transplantation. J Hepatol 2004; 40:3-7.
38. Evans HM, Kelly DA, McKiernan PJ, Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006; 43:1109-1117.